SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000920465-18-000038
Filing Date
2018-10-15
Accepted
2018-10-15 07:02:36
Documents
6
Effectiveness Date
2018-10-15

Document Format Files

Seq Description Document Type Size
1 S-8 s-82018.htm S-8 168079
2 EXHIBIT 5.1 s-8exhibit512018.htm EX-5.1 5957
3 EXHIBIT 23.1 s-8exhibit2312018.htm EX-23.1 3031
4 image1a06.jpg GRAPHIC 19299
5 image3a02.jpg GRAPHIC 19284
6 squara02.jpg GRAPHIC 27403
  Complete submission text file 0000920465-18-000038.txt   253030
Mailing Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121
Business Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-227819 | Film No.: 181121295
SIC: 2836 Biological Products, (No Diagnostic Substances)